Walleye Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-93,327
| Closed | -$1.69M | – | 1943 |
|
|
2025
Q1 | $1.69M | Buy |
+93,327
| New | +$1.69M | 0.01% | 644 |
|
|
2024
Q3 | – | Sell |
-50,183
| Closed | -$1.86M | – | 2541 |
|
|
2024
Q2 | $1.86M | Buy |
50,183
+49,147
| +4,744% | +$1.82M | ﹤0.01% | 849 |
|
|
2024
Q1 | $43.5K | Sell |
1,036
-168,232
| -99% | -$7.06M | ﹤0.01% | 2148 |
|
|
2023
Q4 | $6.71M | Buy |
169,268
+10,275
| +6% | +$408K | 0.01% | 281 |
|
|
2023
Q3 | $4.38M | Buy |
158,993
+37,741
| +31% | +$1.04M | 0.01% | 414 |
|
|
2023
Q2 | $4.11M | Buy |
121,252
+51,436
| +74% | +$1.75M | 0.01% | 340 |
|
|
2023
Q1 | $2.51M | Sell |
69,816
-15,456
| -18% | -$556K | 0.04% | 456 |
|
|
2022
Q4 | $3.8M | Sell |
85,272
-86,630
| -50% | -$3.86M | 0.07% | 306 |
|
|
2022
Q3 | $4.83M | Buy |
+171,902
| New | +$4.83M | 0.09% | 226 |
|
|
2022
Q2 | – | Sell |
-37,381
| Closed | -$1.27M | – | 2348 |
|
|
2022
Q1 | $1.27M | Buy |
37,381
+23,154
| +163% | +$789K | 0.03% | 501 |
|
|
2021
Q4 | $550K | Buy |
+14,227
| New | +$550K | 0.02% | 906 |
|